Free Trial
CVE:VIV

Avivagen (VIV) Stock Price, News & Analysis

Avivagen logo
C$0.0050 0.00 (0.00%)
As of 03/5/2024

About Avivagen Stock (CVE:VIV)

Key Stats

Today's Range
C$0.01
C$0.01
50-Day Range
C$0.01
C$0.01
52-Week Range
C$0.01
C$0.08
Volume
2,820 shs
Average Volume
49,827 shs
Market Capitalization
C$388.45 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VIV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Avivagen and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VIV Stock News Headlines

Avivagen Inc (VIV)
IRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?
On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed professionals, retirees, and high-net-worth savers. But the wealthy aren’t just writing checks. They’re moving fast to protect capital and purchasing power using legal, IRS-compliant strategies. American Alternative Assets just released the Mar-A-Lago Accord, a free guide revealing how to reduce Q3 tax exposure and reposition wealth before it’s drained.tc pixel
Pure Harvest Corporate Group, Inc. (PHCG)
Closing Bell: Avivagen Inc flat on Monday (VIV)
Avivagen Announces New 500Kg Order for OxC-beta™
See More Headlines

VIV Stock Analysis - Frequently Asked Questions

Avivagen's stock was trading at C$0.01 at the beginning of the year. Since then, VIV shares have increased by 0.0% and is now trading at C$0.01.

Shares of VIV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Avivagen investors own include AtkinsRéalis (SNCAF) and ProMetic Life Sciences (PLI).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Communication
Current Symbol
CVE:VIV
CIK
N/A
Fax
N/A
Employees
34,000
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.06)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$4.64 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-193.44%

Debt

Debt-to-Equity Ratio
2,402.32
Current Ratio
0.03
Quick Ratio
0.30

Sales & Book Value

Annual Sales
C$403.78 thousand
Price / Sales
0.96
Cash Flow
C$0.00 per share
Price / Cash Flow
12.14
Book Value
C($0.12) per share
Price / Book
-0.04

Miscellaneous

Outstanding Shares
77,690,000
Free Float
N/A
Market Cap
C$388.45 thousand
Optionable
Not Optionable
Beta
1.06
Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (CVE:VIV) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners